Jon Napitupulu

ICON plc (NASDAQ: ICLR) has released its ICON Cares 2023 Report, outlining its achievements in environmental, social, and governance...

Polo-like kinases (PLKs) are key players in cellular processes like cell cycle regulation and DNA damage response. Their dysregulation...

As a pioneer in oncological and hematological innovation, Massive Bio is showcasing its groundbreaking AI technology at the ASCO...

Lokavant, a clinical trial intelligence platform, has strengthened its team with the appointment of three new Advisory Board members...

Neurogene Inc. has reported positive initial safety and tolerability data from its ongoing Phase 1/2 gene therapy trial for...

ArteraAI has announced the validation of its AI-based digital pathology biomarker for predicting metastasis risk in prostate cancer patients...

Cybin Inc., a biopharmaceutical company specializing in psychedelic-based mental health treatments, has secured $150 million in funding to advance...

Xeris Biopharma and Beta Bionics have entered into an exclusive worldwide collaboration and license agreement to develop and commercialize...

Bristol Myers Squibb (BMS) recently submitted an application to the European Medicines Agency (EMA) for the use of the...

Boehringer Ingelheim and Walgreens have joined forces to revolutionize clinical trials. Through this collaboration, people with obesity, overweight, and...